HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome

Journal of Neuroimmunology

Volumn 159, Issue 1-2, 2005, Pages 230-237

  Wirtz, Paul W ^a   Willcox, Nick ^b   Van Der Slik, Arno R ^a   Lang, Bethan ^b   Maddison, Paul ^b   Koeleman, Bobby P C ^a,c   Giphart, Marius J ^a   Wintzen, Axel R ^a   Roep, Bart O ^a   Verschuuren, Jan J G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoimmunity; HLA antigens; Lambert Eaton myasthenic syndrome; Small cell lung cancer; Smoking

Indexed keywords

CALCIUM CHANNEL; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; HLA DR3 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EATON LAMBERT SYNDROME; FEMALE; GENE LOCUS; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SEROLOGY; SMOKING; STIMULUS RESPONSE;

ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; CHILD; FEMALE; GREAT BRITAIN; HISTOCOMPATIBILITY TESTING; HLA-A1 ANTIGEN; HLA-B8 ANTIGEN; HLA-DR3 ANTIGEN; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SMOKING;

EID: 19944432088     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.10.018     Document Type: Article

References (29)

1. S.R. Burrows, S.L. Silins, D.J. Moss, R. Khanna, I.S. Misko, and V.P. Argaet T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen J. Exp. Med. 182 1995 1703 1715
2. C.H. Chalk, N.M. Murray, J. Newsom-Davis, J.H. O'Neill, and S.G. Spiro Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma Neurology 40 1990 1552 1556
3. R.B. Darnell, and J.B. Posner Observing the invisible: successful tumor immunity in humans Nat. Immunol. 4 2003 201
4. G.P. Dunn, A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber Cancer immunoediting: from immunosurveillance to tumor escape Nat. Immunol. 3 2002 991 998
5. G.M. Elrington, N.M. Murray, S.G. Spiro, and J. Newsom-Davis Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients J. Neurol. Neurosurg. Psychiatry 54 1991 764 767
6. F. Frenken Mannen roken minder, vrouwen niet Statistics Netherlands 2003 Voorburg/Heerlen the Netherlands Electronic Citation
7. F. Graus, J. Dalmau, R. Rene, M. Tora, N. Malats, J.J. Verschuuren, F. Cardenal, N. Vinolas, J. Garcia del Muro, C. Vadell, W.P. Mason, R. Rosell, J.B. Posner, and F.X. Real Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival J. Clin. Oncol. 15 1997 2866 2872
8. S. Haworth, P. Sinnott, J. Davidson, and P. Dyer Caucasian English normal P.I. Terasaki D.W. Gjertson HLA 1997 1997 UCLA Tissue Typing Laboratory Los Angeles 208
9. S. Haworth, J. Davidson, R. Kippax, and P. Dyer Caucasian English normal P.I. Terasaki D.W. Gjertson HLA 1998 1998 American Society for Histocompatibility and Immunogenetics Lenexa 133
10. M. Janer, A. Cowland, J. Picard, D. Campbell, P. Pontarotti, J. Newsom-Davis, M. Bunce, K. Welsh, A. Demaine, A.G. Wilson, and N. Willcox A susceptibility region for myasthenia gravis extending into the HLA- class I sector telomeric to HLA-C Hum. Immunol. 60 1999 909 917
11. V.A. Lennon, T.J. Kryzer, G.E. Griesmann, P.E. O'Suilleabhain, A.J. Windebank, A. Woppmann, G.P. Miljanich, and E.H. Lambert Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes N. Engl. J. Med. 332 1995 1467 1474
12. D. Lio, G. Candore, A. Colombo, R.G. Colonna, F. Gervasi, V. Marino, L. Scola, and C. Caruso A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity Hum. Immunol. 62 2001 705 713
13. A. Machens, C. Loliger, U. Pichlmeier, T. Emskotter, C. Busch, and J.R. Izbicki Correlation of thymic pathology with HLA in myasthenia gravis Clin. Immunol. 91 1999 296 301
14. P. Maddison, J. Newsom-Davis, K.R. Mills, and R.L. Souhami Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma Lancet 353 1999 117 118
15. M. Markman, H.G. Braine, and M.D. Abeloff Histocompatibility antigens in small cell carcinoma of the lung Cancer 54 1984 2943 2945
16. C.S. Morris, M.M. Esiri, A. Marx, and J. Newsom-Davis Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome Am. J. Pathol. 140 1992 839 845
17. M. Motomura, B. Lang, I. Johnston, J. Palace, A. Vincent, and J. Newsom-Davis Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome J. Neurol. Sci. 147 1997 35 42
18. J.H. O'Neill, N.M. Murray, and J. Newsom-Davis The Lambert-Eaton myasthenic syndrome. A review of 50 cases Brain 111 1988 577 596
19. M. Paesmans, J.P. Sculier, J. Lecomte, J. Thiriaux, P. Libert, R. Sergysels, G. Bureau, G. Dabouis, O. Van Cutsem, P. Mommen, V. Ninane, and J. Klastersky Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years Cancer 89 2000 523 533
20. K.T. Parsons, W.W. Kwok, L.K. Gaur, and G.T. Nepom Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert-Eaton myasthenic syndrome without associated cancer Hum. Immunol. 61 2000 828 833
21. P. Price, C. Witt, R. Allcock, D. Sayer, M. Garlepp, C.C. Kok, M. French, S. Mallal, and F. Christiansen The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases Immunol. Rev. 167 1999 257 274
22. A. Roberts, S. Perera, B. Lang, A. Vincent, and J. Newsom-Davis Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line Nature 317 1985 737 739
23. R.F. Schipper, G.M. Schreuder, J. D'Amaro, and M. Oudshoorn HLA gene and haplotype frequencies in Dutch blood donors Tissue Antigens 48 1996 562 574
24. M. Uchuya, A. Fleury, F. Graus, D. Costagliola, R. Liblau, H. Merle-Beral, I. Theodorou, and J.Y. Delattre Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer Neurology 50 1998 565 566
25. N. Willcox, A.G. Demaine, J. Newsom-Davis, K.I. Welsh, S.A. Robb, and S.G. Spiro Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma Hum. Immunol. 14 1985 29 36
26. P.W. Wirtz, B.O. Roep, G.M. Schreuder, P.A. Van Doorn, B.G. van Engelen, J.B. Kuks, A. Twijnstra, M. de Visser, L.H. Visser, J.H. Wokke, A.R. Wintzen, and J.J. Verschuuren HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor Hum. Immunol. 62 2001 809 813
27. P.W. Wirtz, T.W.J. Huizinga, D.-J. Stoeken, A.R. Wintzen, and J.J. Verschuuren High innate production of interleukin-10 and tumor necrosis factor-alfa contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome J. Neuroimmunol. 140 2003 194 197
28. W. Zaheer, M.L. Friedland, E.B. Cooper, A. DoRosario, R.M. Burd, J. Gagliardi, and G. Torstenson Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy Cancer Investig. 11 1993 306 309
29. E. Zanelli, G. Jones, M. Pascual, P. Eerligh, A.R. van der Slik, A.H. Zwinderman, W. Verduyn, G.M. Schreuder, E. Roovers, F.C. Breedveld, R.R. de Vries, J. Martin, and M.J. Giphart The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci Hum. Immunol. 62 2001 75 84